BioCentury
ARTICLE | Company News

Samaritan, Three Rivers Pharmaceuticals sales and marketing update

October 15, 2007 7:00 AM UTC

The companies extended a distribution deal for Three Rivers' Amphocil amphotericin B, a proton pump inhibitor, to include Ireland. LIV already had exclusive marketing rights to the invasive aspergill...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article